Katherine E. Jacobitz
FDA investigator
Appears on 3 documents from 2017 to 2026, mostly at sites in California. Most often cites general requirements (21 CFR 211.160(a)).
- 3
- Documents on file
- 5.0
- Observations per 483
- 2017
- First seen
- 2026
- Most recent
What they cite most
From 15 observations- 21 CFR 211.160(a)General requirements4
- 21 CFR 8201
- 21 CFR 211.142Warehousing procedures1
- 21 CFR 211.165(e)Testing and release for distribution1
- 21 CFR 211.188(b)(7)Batch production and control records1
- 21 CFR 211.192Production record review1
Activity by year
2017: 1, 2025: 1, 2026: 1
Where
California 2 · Washington 1
Often inspects with
Is Katherine E. Jacobitz coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-06-17 | 483 Jubilant HollisterStier LLCJun 17, 2026 · Spokane, Washington | Spokane, Washington | 2 | |
| 2025-09-04 | 483 Sparsha Pharma Usa IncSep 4, 2025 · Oceanside, California | Oceanside, California | 10 | |
| 2017-04-06 | 483 PCI San Diego, Inc.Apr 6, 2017 · San Diego, California | San Diego, California | 3 |
About this profile
What does Katherine E. Jacobitz inspect?
Katherine E. Jacobitz appears on 3 documents on file covering 3 sites, mostly in California.
What do they cite most often?
21 CFR 211.160(a) (general requirements), followed by 21 CFR 820 and 21 CFR 211.142.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Katherine E. Jacobitz is dated Jun 17, 2026.